Taylor, Cottrill, Erickson & Associates, Inc. Lemaitre Vascular Inc Transaction History
Taylor, Cottrill, Erickson & Associates, Inc.
- $338 Million
- Q2 2024
A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 3,264 shares of LMAT stock, worth $299,341. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,264
Previous 3,257
0.21%
Holding current value
$299,341
Previous $216,000
24.07%
% of portfolio
0.08%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding LMAT
# of Institutions
266Shares Held
20.3MCall Options Held
3.6KPut Options Held
900-
Black Rock Inc. New York, NY3.48MShares$319 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$178 Million2.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$143 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.15MShares$106 Million1.81% of portfolio
-
Geneva Capital Management LLC880KShares$80.7 Million1.33% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.01B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...